Description
The abstract states that PGC1α overexpression reduces Aβ by regulating BACE1 expression, but the precise transcriptional or post-transcriptional mechanisms are not explained. Understanding this pathway is critical for developing targeted therapeutic interventions.
Gap type: unexplained_observation Source paper: The Role of PGC1α in Alzheimer’s Disease and Therapeutic Interventions. (2021, Int J Mol Sci, PMID:34071270)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:36.916616+00:00”, “resolution_summary”: “Resolved by hypothesis h-a6e77292: SGMS1-Driven Sphingomyelin Accumulation Impairs BACE1 Lysosomal Degradation via Autophagosome-Lysosome Fusion Dysfunction. Supporting evidence includes debate sess_SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-a6e77292”, “title”: “SGMS1-Driven Sphingomyelin Accumulation Impairs BACE1 Lysosomal Degradation via Autophagosome-Lysosome Fusion Dysfunction”, “score”: 0.226, “reason”: “17 token overlaps; entity overlap: bace1”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-083737-59771b32”, “target_gene”: “SGMS1, BECN1”, “target_pathway”: “Autophagy / beclin-1”, “disease”: “neurodegeneration”, “composite_score”: 0.734, “confidence_score”: 0.72, “status”: “promoted”, “pubmed_evidence_ids”: [“23827971”, “23977395”, “28028177”, “30243987”, “N/A”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0_task_9aae8fc5”, “title”: “The abstract mentions that pathological seeds have different characteristics and conformations, but the underlying molecular mechanisms that generate this diversity remain unclear. Understanding these mechanisms is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: Protein transmission in neurodegenerative disease. (2020, Nat Rev Neurol, PMID:32203399)”, “score”: 0.611, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062207-e4ce5cf0”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-093843-0a9326c2_20260416-032731”, “title”: “The abstract identifies BACE1 as an attractive drug target but doesn’t address its normal physiological roles. Understanding these functions is critical to predict potential adverse effects of BACE1 inhibitors in therapeutic development.\n\nGap type: open_question\nSource paper: BACE1: the beta-secretase enzyme in Alzheimer’s disease. (2004, Journal of molecular neuroscience : MN, PMID:15126696)”, “score”: 0.597, “reason”: “10 token overlaps; entity overlap: bace1, pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-093843-0a9326c2”, “quality_score”: 0.76, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-083737-59771b32_20260416-033540”, “title”: “The study demonstrates that SGMS1 elevation correlates with increased Aβ and that SGMS inhibition reduces Aβ production, but the specific biochemical pathways connecting sphingomyelin metabolism to APP processing remain unexplained. Understanding this mechanism is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: Elevation in sphingomyelin synthase activity is associated with increases in amyloid-beta peptide generation. (None, None, PMID:23977395)”, “score”: 0.584, “reason”: “15 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-083737-59771b32”, “quality_score”: 0.75, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2_20260416-033018”, “title”: “The abstract shows p53 is a central regulator of C9orf72-mediated neurodegeneration but doesn’t explain how poly(PR) specifically activates p53. Understanding this upstream trigger mechanism is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). (None, None, PMID:33482083)”, “score”: 0.576, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-06-gap-pubmed-20260406-062118-e3613755_task_9aae8fc5”, “title”: “The study shows SPP1 from perivascular cells drives microglial synaptic engulfment, but the specific receptors, signaling pathways, and molecular cascades linking SPP1 to phagocytic gene expression remain undefined. Understanding this mechanism is critical for developing targeted therapeutics that could modulate pathological synaptic loss.\n\nGap type: unexplained_observation\nSource paper: Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer’s disease. (2023, Nat Neurosci, PMID:36747024)”, “score”: 0.573, “reason”: “14 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-062118-e3613755”, “quality_score”: 0.704, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}